试验医学大麻的随机试验,以减少新诊断的晚期胰腺癌 (CanPan) 患者的症状负担
Dylan Zylla1, Ella Chrenka2, Kendall Lin3
1HealthPartners Institute, Cancer Research Center, Minneapolis, MN.
JCO oncology practice
|January 9, 2026
概括
这项试点研究表明,医用大麻可能有助于管理胰腺癌患者的疼痛和失眠等症状. 与州政府计划合作可以克服未来试验的研究障碍.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 大麻研究 大麻研究
背景情况:
- 胰腺癌患者经常出现严重的症状.
- 医用大麻显示出对症状管理的潜力.
- 高质量的研究受到监管障碍的限制.
研究的目的:
- 对胰腺癌患者进行医疗大麻干预的可行性和可接受性进行评估.
- 探索医用大麻用于症状管理的初步疗效和安全性.
- 展示大麻研究的新型合作模式.
主要方法:
- 一项试点随机等候名单受控试验,涉及32名胰腺腺癌患者.
- 患者通过明尼苏达州医用大麻计划接受了医用大麻干预.
- 评估了可行性,可接受性,症状负担和生活质量.
主要成果:
- 该研究满足了招生,合规性和结果完成的可行性基准.
- 患者报告了大量的基线症状负担 (失眠,疼痛,食欲丧失).
- 探索性分析显示,早期干预组的症状改善率在数值上更高.
结论:
- 与州大麻计划的合作模式可以克服大麻研究中的监管障碍.
- 医用大麻显示了令人鼓舞的初步疗效和胰腺癌症状管理的安全性.
- 需要进一步的研究来证实这些发现.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
665
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
665
01:29Chronic Pancreatitis II: Collaborative Care
307
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
307